BR9608909A - Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto - Google Patents
Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do compostoInfo
- Publication number
- BR9608909A BR9608909A BR9608909A BR9608909A BR9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A
- Authority
- BR
- Brazil
- Prior art keywords
- animals
- compound
- increase
- growth
- patuitaria
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000002268 wool Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK71995 | 1995-06-22 | ||
| DK137195 | 1995-12-04 | ||
| PCT/DK1996/000266 WO1997000894A1 (en) | 1995-06-22 | 1996-06-19 | Compounds with growth hormone releasing properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9608909A true BR9608909A (pt) | 1999-03-02 |
Family
ID=26064522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9608909A BR9608909A (pt) | 1995-06-22 | 1996-06-19 | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0833845A1 (hu) |
| KR (1) | KR19990028303A (hu) |
| AU (1) | AU711104B2 (hu) |
| BR (1) | BR9608909A (hu) |
| CA (1) | CA2224434A1 (hu) |
| CZ (1) | CZ287948B6 (hu) |
| HU (1) | HUP9802821A3 (hu) |
| IL (1) | IL122371A0 (hu) |
| NO (1) | NO975992L (hu) |
| PL (1) | PL186520B1 (hu) |
| TW (1) | TW458958B (hu) |
| WO (1) | WO1997000894A1 (hu) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3938797A (en) * | 1996-08-29 | 1998-03-19 | Novo Nordisk A/S | Transdermal delivery of peptides |
| US6127341A (en) * | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU7906998A (en) | 1997-06-20 | 1999-01-04 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| DE69836386T2 (de) | 1997-08-22 | 2007-10-11 | Kaken Pharmaceutical Co., Ltd. | Amide zur Förderung der Ausschüttung von Wachstumshormonen |
| EP1506969B1 (en) | 1998-01-16 | 2010-06-09 | Helsinn Therapeutics (U.S.), Inc. | Compounds with growth hormone releasing properties |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| EP1077949A2 (en) * | 1998-05-12 | 2001-02-28 | Warner-Lambert Company | Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| WO2000001726A1 (en) * | 1998-06-30 | 2000-01-13 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6919315B1 (en) | 1998-06-30 | 2005-07-19 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| AU5671099A (en) | 1998-08-14 | 2000-03-06 | The Administrators Of The Tulane Eductional Fund | Compounds having growth hormone releasing activity |
| EP1158996A4 (en) | 1999-02-18 | 2005-01-12 | Kaken Pharma Co Ltd | NEW AMID DERIVATIVES AS GROWTH HORMONE SECRETION CONVEYORS |
| ES2333097T3 (es) | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal. |
| AR035773A1 (es) | 2000-12-20 | 2004-07-14 | Bristol Myers Squibb Pharma Co | Compuestos diamino ciclico, composicion farmaceutica y su uso en la fabricacion de un medicamento util para modular la actividad de una quimioquina |
| CA2432908A1 (en) | 2000-12-20 | 2002-06-27 | Bristol-Myers Squibb Pharma Company | Diamines as modulators of chemokine receptor activity |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| BRPI0807046A2 (pt) | 2007-02-09 | 2015-05-26 | Tranzyme Pharma Inc | Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit. |
| CA2710039C (en) | 2007-12-26 | 2018-07-03 | Critical Outcome Technologies, Inc. | Semicarbazones, thiosemicarbazones and related compounds and methods for treatment of cancer |
| WO2010006438A1 (en) | 2008-07-17 | 2010-01-21 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| US8987272B2 (en) | 2010-04-01 | 2015-03-24 | Critical Outcome Technologies Inc. | Compounds and method for treatment of HIV |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| UA42747C2 (uk) * | 1993-12-23 | 2001-11-15 | Ново Нордіск А/С | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту |
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
-
1996
- 1996-06-19 HU HU9802821A patent/HUP9802821A3/hu unknown
- 1996-06-19 IL IL12237196A patent/IL122371A0/xx not_active IP Right Cessation
- 1996-06-19 KR KR1019970709617A patent/KR19990028303A/ko not_active Application Discontinuation
- 1996-06-19 AU AU61882/96A patent/AU711104B2/en not_active Ceased
- 1996-06-19 EP EP96920742A patent/EP0833845A1/en not_active Withdrawn
- 1996-06-19 CA CA002224434A patent/CA2224434A1/en not_active Abandoned
- 1996-06-19 WO PCT/DK1996/000266 patent/WO1997000894A1/en not_active Application Discontinuation
- 1996-06-19 PL PL96324200A patent/PL186520B1/pl unknown
- 1996-06-19 BR BR9608909A patent/BR9608909A/pt not_active Application Discontinuation
- 1996-06-19 CZ CZ19974081A patent/CZ287948B6/cs not_active IP Right Cessation
- 1996-06-28 TW TW085107813A patent/TW458958B/zh not_active IP Right Cessation
-
1997
- 1997-12-19 NO NO975992A patent/NO975992L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ287948B6 (cs) | 2001-03-14 |
| CA2224434A1 (en) | 1997-01-09 |
| EP0833845A1 (en) | 1998-04-08 |
| NO975992D0 (no) | 1997-12-19 |
| MX9710377A (es) | 1998-03-29 |
| WO1997000894A1 (en) | 1997-01-09 |
| IL122371A0 (en) | 1998-06-15 |
| AU711104B2 (en) | 1999-10-07 |
| TW458958B (en) | 2001-10-11 |
| HUP9802821A3 (en) | 2000-03-28 |
| HUP9802821A2 (hu) | 1999-03-29 |
| KR19990028303A (ko) | 1999-04-15 |
| NO975992L (no) | 1998-02-20 |
| JPH11507928A (ja) | 1999-07-13 |
| PL324200A1 (en) | 1998-05-11 |
| AU6188296A (en) | 1997-01-22 |
| JP4173541B2 (ja) | 2008-10-29 |
| CZ408197A3 (cs) | 1998-05-13 |
| PL186520B1 (pl) | 2004-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9608909A (pt) | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto | |
| BR9608956A (pt) | Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto | |
| PT912194E (pt) | Formula de vacina polinucleotidica particularmente contra doenca respiratoria dos bovinos | |
| ATE178204T1 (de) | Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer | |
| BR8707572A (pt) | Composicao para tratamento de pele resistente a umidade | |
| DE3876756D1 (de) | Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe. | |
| BR9609670A (pt) | Compostos processos para a preparação dos mesmos uso dos mesmos e processos de controlar pestes fúngicidas e pestes animais | |
| DE68916430D1 (de) | Arzneimittelzubereitung zur behandlung von mastitis bei tier und mensch. | |
| BR9605907A (pt) | Formulaçao de liberaçao prolongada de um hormônio de crescimento animal e processo para sua preparaçao | |
| ITMI951538A0 (it) | Procedimento ed impianto per la disidratazione di foraggio particolarmente per la disidratazione dell'erba medica | |
| FR2748394B1 (fr) | Applicateur de medicaments pour animaux | |
| BR9603012A (pt) | Composição de resina produto moldado coleira brinco e medalha para animais processo para controlar a exsudação do composto ativo e uso do produto moldado | |
| BR9506235A (pt) | Compostos enanciométricos únicos uso dos mesmos processos para sua preparação e de(+)-e-(-)-5-carbometoxi-6-metail-2-((3,4-dimetoxi-2-piridinil)metil )1-h-benzimidazol ou seu sal de sódio em suas for mas cristalinas para inibição de secreção de ácido gástrico e para o tratamento de doenças inflamatórias gastrointestinais e preparação farmacêutica | |
| FI972949A0 (fi) | Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä | |
| BR9709930A (pt) | Composto composição farmacêutica uso de um composto e processos para tratamento de um indivíduo humano ou animal e para preparação de um composto | |
| ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| BR9607101A (pt) | Composto formulação farmacéutica e processos para tratar tumores de animais ou de seres humanos e para produzir um composto | |
| BR8604290A (pt) | Esteres heterociclilalquilicos de acidos-2-imidazolinou,nicotinicos,processo para sua preparacao,composicao herbicida e processos para o combate seletivo e para inibir e suprimir o crescimento de plantas e para a dessecacao e desfolhamento de culturas | |
| AU1581795A (en) | Lure for facilitating the administration of drugs to certain animals, particularly dogs | |
| BR9200318A (pt) | Derivados de 3-aril-pirrolidin-2,4-diona biciclicos-substituidos,processo para a sua preparacao,composicoes praguicidas,processo para o combate de pragas animais,aplicacao dos ditos derivados,processo para a preparacao de praguicidas,processo para o combate de ervas daninhas e processo para a preparacao de composicoes herbicidas | |
| FR2751177B1 (fr) | Compositions exemptes de proteines et de peptides obtenues a partir de toutes proteines animales, destinees a l'alimentation animale et humaine, ainsi qu'a l'usage cosmetique pharmaceutique et agricole | |
| ATE292458T1 (de) | Transdermales therapeutisches system zur verabreichung von (s)-3-methyl-5-(1-methyl-2- pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen salze | |
| FR2739778B1 (fr) | Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal | |
| BR9501691A (pt) | Derivado de ácido graxo processo para a preparação de um derivado de ácido graxo composição farmacêutica e método para a prevenção e ou tratamento de doenças humanas ou animais | |
| FR2683147B1 (fr) | Systeme vehicule de principe actif permettant l'administration voie orale chez les poissons et crustaces. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |